Atlas Trials

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Clinical trial NCT06381323 · COMPLETED

Trial details

NCT number
NCT06381323
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary AldosteronismFinerenoneMineralocorticoid Receptor Antagonist
Start date
2024-03-01
Primary completion
2025-06-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.